Down regulation of microRNA-155 may underlie age-related hypertension

Hypertension and cardiac disease are common consequences of aging. Unfortunately, many elderly individuals do not respond to current therapies for reducing blood pressure, and the factors that drive age-related hypertension are poorly understood.

In this issue of JCI Insight, researchers led by Iris Jaffe of Tufts Medical Center provide evidence that age-related reductions of a microRNA (miR-155) underlie age-associated hypertension. Mice that lack mineralocorticoid receptors in , which regulate blood pressure, are protected from developing high blood pressure as they age.

Jaffe and colleagues determined that compared to aged wild type mice, aged animals lacking have elevated levels of miR-155, less oxidative stress, and fewer hypertensive characteristics. Moreover, restoration of miR-155 in aged wild type mice improved blood pressure parameters.

Importantly, in a small cohort of healthy older adults treated with a mineralocorticoid receptor inhibitor, reduced levels of miR-155 were associated with beneficial changes in . Together, these results indicate that miR-155 should be further explored as a biomarker and therapeutic target for age-related hypertension.

Explore further

Genetically altering female mice prevents diet-induced obesity, study shows

More information: Jennifer J. DuPont et al, Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging, JCI Insight (2016). DOI: 10.1172/jci.insight.88942
Provided by JCI Journals
Citation: Down regulation of microRNA-155 may underlie age-related hypertension (2016, September 8) retrieved 5 July 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments